188 related articles for article (PubMed ID: 27264946)
1. Establishment and use of surgical rat models for assessment of organ specific in vivo clearance.
Vestergaard B
Dan Med J; 2016 Jun; 63(6):. PubMed ID: 27264946
[TBL] [Abstract][Full Text] [Related]
2. The kidneys play an important role in the clearance of rFVIIa in rats.
Vestergaard B; Appa RS; Lykkesfeldt J; Agersø H
Thromb Res; 2014 Jun; 133(6):1124-9. PubMed ID: 24731563
[TBL] [Abstract][Full Text] [Related]
3. The kidneys play a central role in the clearance of rhGH in rats.
Vestergaard B; Thygesen P; Kreilgaard M; Fels JJ; Lykkesfeldt J; Agersø H
Eur J Pharm Sci; 2016 Apr; 86():29-33. PubMed ID: 26946443
[TBL] [Abstract][Full Text] [Related]
4. Nephrectomized and hepatectomized animal models as tools in preclinical pharmacokinetics.
Vestergaard B; Agersø H; Lykkesfeldt J
Basic Clin Pharmacol Toxicol; 2013 Aug; 113(2):75-86. PubMed ID: 23586405
[TBL] [Abstract][Full Text] [Related]
5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
6. Altered disposition of drugs in acute renal failure rat models: drug development strategies and perspectives.
Srinivas NR
Arzneimittelforschung; 2010; 60(12):731-48. PubMed ID: 21265465
[TBL] [Abstract][Full Text] [Related]
7. Effects of hepatectomy, nephrectomy, and nephrectomy/uremia on the metabolism of parathyroid hormone in the rat.
Segre GV; D'Amour P; Hultman A; Potts JT
J Clin Invest; 1981 Feb; 67(2):439-48. PubMed ID: 7462426
[TBL] [Abstract][Full Text] [Related]
8. Fate of circulating oxalate in rats.
Sugimoto T; Osswald H; Yamamoto K; Kanazawa T; Iimori H; Funae Y; Kamikawa S; Kishimoto T
Eur Urol; 1993; 23(4):485-9. PubMed ID: 8335055
[TBL] [Abstract][Full Text] [Related]
9. Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRN8601) in the rat.
Tanaka H; Tokiwa T
Cancer Res; 1990 Oct; 50(20):6615-9. PubMed ID: 1698539
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
11. Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.
Hamscho N; Wilhelm A; Döbert N; Menzel C; Gossmann J; Berner U; Zaplatnikov K; Scheuermann EH; Grünwald F
Nuklearmedizin; 2005; 44(5):200-4. PubMed ID: 16395496
[TBL] [Abstract][Full Text] [Related]
12. Leptin is cleared from the circulation primarily by the kidney.
Cumin F; Baum HP; Levens N
Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1120-6. PubMed ID: 8968858
[TBL] [Abstract][Full Text] [Related]
13. The functional capacity of hypertrophied nephrons. Effect of partial nephrectomy on the clearance of inulin and PAH in the rat.
Morrison AB; Howard RM
J Exp Med; 1966 May; 123(5):829-44. PubMed ID: 5938815
[TBL] [Abstract][Full Text] [Related]
14. Influence of the degree of renal dysfunction on the pharmacokinetic properties of the novel recombinant plasminogen activator reteplase in rats.
Martin U; Doerge L; Stegmeier K; Müller-Beckmann B
Drug Metab Dispos; 1996 Mar; 24(3):288-92. PubMed ID: 8820418
[TBL] [Abstract][Full Text] [Related]
15. In vivo analysis of amantadine renal clearance in the uninephrectomized rat: functional significance of in vitro bicarbonate-dependent amantadine renal tubule transport.
Goralski KB; Smyth DD; Sitar DS
J Pharmacol Exp Ther; 1999 Aug; 290(2):496-504. PubMed ID: 10411555
[TBL] [Abstract][Full Text] [Related]
16. Suitability of 5/6 nephrectomy (5/6NX) for the induction of interstitial renal fibrosis in rats--influence of sex, strain, and surgical procedure.
Fleck C; Appenroth D; Jonas P; Koch M; Kundt G; Nizze H; Stein G
Exp Toxicol Pathol; 2006 Jan; 57(3):195-205. PubMed ID: 16410187
[TBL] [Abstract][Full Text] [Related]
17. Application of an in vitro OAT assay in drug design and optimization of renal clearance.
Soars MG; Barton P; Elkin LL; Mosure KW; Sproston JL; Riley RJ
Xenobiotica; 2014 Jul; 44(7):657-65. PubMed ID: 24417751
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic study on oxalate in rats].
Sugimoto T; Katoh Y; Matsumura T; Kishimoto T; Yamamoto K; Kanazawa T; Senju M; Maekawa M
Hinyokika Kiyo; 1988 Jul; 34(7):1135-40. PubMed ID: 3051947
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial impairment in the five-sixth nephrectomy model of chronic renal failure: proteomic approach.
Fedorova LV; Tamirisa A; Kennedy DJ; Haller ST; Budnyy G; Shapiro JI; Malhotra D
BMC Nephrol; 2013 Oct; 14():209. PubMed ID: 24090408
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of rFVIIa and new improved bypassing agents for the treatment of haemophilia.
Agersø H; Tranholm M
Haemophilia; 2012 Jul; 18 Suppl 5():6-10. PubMed ID: 22757678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
